Unlocking Real-World Data with AI Horizon Europe Project. Funded by the European Union (Grant agreement ID: 101095353).

Joined June 2023
🚀 We’re excited to announce that the #Real4Reg project is now on Bluesky! Follow us to join the conversation and stay informed on our progress. 📲 bsky.app/profile/real4reg.bs…
1
23
As part of the #MetReal cluster, we joined the Multi-Stakeholder Workshop on RWD in regulatory & HTA decision-making in Bonn! Organized by @Real4Reg, the event brought together key stakeholders to advance #RWD use in Europe.💡 🔗 Read more: reddie-diabetes.eu/news/mult…
1
5
6
239
Multi-Stakeholder Workshop on RWD in regulatory & HTA decision-making in Bonn! We had a very fruitful hybrid workshop at the @bfarm_de in Bonn on 6 February 2025, bringing together a diverse group of stakeholders.
1
2
5
264
We are truly grateful for all the insightful discussions and valuable input we received. The energy and engagement from all participants is shaping the future of healthcare decision-making.
1
1
15
Real4Reg Partners’ Participation in Key Events: A Brief Recap of 2024 💡 As 2025 begins, it’s the perfect time to reflect on the key events that shaped #Real4Reg in 2024. Check out the full article on our website to learn more about our journey! real4reg.eu/news-events/news…
1
3
187
🔬31st Annual Meeting of the German Drug Utilitsation Research Group (GAA e.V. - Gesellschaft für Arzneimittelanwendungsforschung und Arzneimitteltherapie): Real4Reg informs about feasibility of #RWD-based external control arms for single-arm trials.
1
1
14
#Real4Reg members participated in the GAA’s 31st Annual Meeting, held from 21-22 November 2024 at @bfarm_de in Bonn. At the opening ceremony, the President of the @bfarm_de Prof. Dr. Karl Broich, briefly highlighted Real4Reg in the context of the #MetReal cluster.
1
1
22
Martin Russek presented a study evaluating the feasibility of supplementing single-arm trials with external control arms based on German #RWD sources. We are delighted that his poster was awarded 1st place in the poster price recognizing the importance of his work.
1
12
In our September newsletter, we took a deep dive into the challenges of causal inference in Real-World Data (#RWD) analysis, exploring how Causal Machine Learning (#ML) can enhance the RWD analysis toolbox. At Real4Reg, we are applying these techniques to different tasks.
1
2
23
🚀 Today, November 12, we held the last Consortium Meeting of 2024! As we are about to conclude the second year of the #Real4Reg project, this meeting brought together our project partners for a day of productive in-depth discussions.
1
2
20
Two invited talks were presented: 🎤 Andreas Kremer (Information Technology for Translational Medicine) gave a talk on #OMOP-CDM 🎤 Zaide Frias (@EMA_News) gave a talk on the EU Network Training Centre (EU-NTC).
1
1
16
We are grateful for the opportunity to learn from such distinguished speakers, and the discussions that followed provided valuable perspectives to shape the future of the project!
1
10
Reminder: Join Us for the Real4Reg 2024 Workshops! We’re thrilled to remind you about our two upcoming workshops focused on the evolving world of Real-World Data (RWD) and Real-World Evidence (RWE), designed for both professionals and patients! real4reg.eu/news-events/news…
1
2
3
78
First Event: Insights into Stakeholder Needs 🕒 Time: 09:30–11:00 (CEST) 🔗 Register here: docs.google.com/forms/d/1lW0…
1
14
Second Event: Demystifying Real-World Data – Insights for Patients 🕒 Time: 11:30–13:00 (CEST) 🔗 Register here: docs.google.com/forms/d/1WcW…
13